» Articles » PMID: 36949458

The Oral Microbiome in Autoimmune Diseases: Friend or Foe?

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2023 Mar 23
PMID 36949458
Authors
Affiliations
Soon will be listed here.
Abstract

The human body is colonized by abundant and diverse microorganisms, collectively known as the microbiome. The oral cavity has more than 700 species of bacteria and consists of unique microbiome niches on mucosal surfaces, on tooth hard tissue, and in saliva. The homeostatic balance between the oral microbiota and the immune system plays an indispensable role in maintaining the well-being and health status of the human host. Growing evidence has demonstrated that oral microbiota dysbiosis is actively involved in regulating the initiation and progression of an array of autoimmune diseases.Oral microbiota dysbiosis is driven by multiple factors, such as host genetic factors, dietary habits, stress, smoking, administration of antibiotics, tissue injury and infection. The dysregulation in the oral microbiome plays a crucial role in triggering and promoting autoimmune diseases via several mechanisms, including microbial translocation, molecular mimicry, autoantigen overproduction, and amplification of autoimmune responses by cytokines. Good oral hygiene behaviors, low carbohydrate diets, healthy lifestyles, usage of prebiotics, probiotics or synbiotics, oral microbiota transplantation and nanomedicine-based therapeutics are promising avenues for maintaining a balanced oral microbiome and treating oral microbiota-mediated autoimmune diseases. Thus, a comprehensive understanding of the relationship between oral microbiota dysbiosis and autoimmune diseases is critical for providing novel insights into the development of oral microbiota-based therapeutic approaches for combating these refractory diseases.

Citing Articles

Oral Pathogens' Substantial Burden on Cancer, Cardiovascular Diseases, Alzheimer's, Diabetes, and Other Systemic Diseases: A Public Health Crisis-A Comprehensive Review.

Murray P, Coffman J, Garcia-Godoy F Pathogens. 2025; 13(12.

PMID: 39770344 PMC: 11677847. DOI: 10.3390/pathogens13121084.


Unveiling the skin microbial guardians and assailants in psoriasis subtypes: a Mendelian randomization study.

Zhang Z, Jiang N, Zhang Y, Yu Q, Jiang Y, Li F Arch Dermatol Res. 2024; 317(1):95.

PMID: 39656273 DOI: 10.1007/s00403-024-03602-z.


Oral Microbiome: A Review of Its Impact on Oral and Systemic Health.

Rajasekaran J, Krishnamurthy H, Bosco J, Jayaraman V, Krishna K, Wang T Microorganisms. 2024; 12(9).

PMID: 39338471 PMC: 11434369. DOI: 10.3390/microorganisms12091797.


Sputum production and salivary microbiome in COVID-19 patients reveals oral-lung axis.

Lu K, Alqaderi H, Bin Hasan S, AlHazmi H, Alghounaim M, Devarajan S PLoS One. 2024; 19(7):e0300408.

PMID: 39052548 PMC: 11271936. DOI: 10.1371/journal.pone.0300408.


The oral microbiome and oral and upper gastrointestinal diseases.

Liu S, Wang S, Zhang N, Li P J Oral Microbiol. 2024; 16(1):2355823.

PMID: 38835339 PMC: 11149586. DOI: 10.1080/20002297.2024.2355823.


References
1.
Chaves I, Zicker M, Laranjeira A, Silveira A, Aguiar D, Barrioni B . Dysbiotic oral microbiota contributes to alveolar bone loss associated with obesity in mice. J Appl Oral Sci. 2022; 30:e20220238. PMC: 9724496. DOI: 10.1590/1678-7757-2022-0238. View

2.
Ruff W, Greiling T, Kriegel M . Host-microbiota interactions in immune-mediated diseases. Nat Rev Microbiol. 2020; 18(9):521-538. DOI: 10.1038/s41579-020-0367-2. View

3.
Naka S, Wato K, Misaki T, Ito S, Matsuoka D, Nagasawa Y . Streptococcus mutans induces IgA nephropathy-like glomerulonephritis in rats with severe dental caries. Sci Rep. 2021; 11(1):5784. PMC: 7952735. DOI: 10.1038/s41598-021-85196-4. View

4.
Jensen E, Selway C, Allen G, Bednarz J, Weyrich L, Gue S . Early markers of periodontal disease and altered oral microbiota are associated with glycemic control in children with type 1 diabetes. Pediatr Diabetes. 2021; 22(3):474-481. DOI: 10.1111/pedi.13170. View

5.
Rapone B, Ferrara E, Corsalini M, Converti I, Grassi F, Santacroce L . The Effect of Gaseous Ozone Therapy in Conjunction with Periodontal Treatment on Glycated Hemoglobin Level in Subjects with Type 2 Diabetes Mellitus: An Unmasked Randomized Controlled Trial. Int J Environ Res Public Health. 2020; 17(15). PMC: 7432743. DOI: 10.3390/ijerph17155467. View